Progyny, Inc. P/E ratio

P/E ratio of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current P/E ratio of Progyny, Inc. is 90.19 (as of December 30, 2020)
  • P/E ratio for the quarter ending September 29, 2021 was 62.22 (a -17.74% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio decreased by -31.01%
  • Annual P/E ratio for 2020 was 90.19 (a Infinity% increase from previous year)
  • Annual P/E ratio for 2019 was 0.0 (a NaN% decrease from previous year)
  • Annual P/E ratio for 2018 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Progyny, Inc.

Most recent P/E ratioof PGNY including historical data for past 10 years.

Interactive Chart of P/E ratio of Progyny, Inc.

Progyny, Inc. P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 62.22 75.64 78.09
2020 90.19 2943.0 0.0 0.0 90.19
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0
2017 0.0

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.